A comprehensive framework for Causal Machine Learning with continuous treatments, designed for real-world industrial applications.
This repository implements the methodology described in our KDD 2025 paper: "An end-to-end pipeline for Causal ML with continuous treatments: An application to financial decision making". The framework addresses critical challenges in applying causal inference to industrial-scale problems, including high dimensionality, positivity assumption violations, and continuous treatment effects.
- Positivity Assumption Violation Handling: Framework to detect and quantify positivity violations in continuous treatment settings + different remediation strategies suggestions.
- Scalable Dimensionality Reduction: Two-stage selection framework specifically designed for causal inference with high-dimensional data.
- Continuous Treatment Adaptations: Extension of sensitivity analysis and estimation methods from binary to continuous treatments.
- End-to-End Integration: Complete modular workflow bridging the gap between academic theory and practical implementation.
Traditional causal inference methods face significant limitations in industrial applications:
- High dimensionality in modern datasets creates computational and statistical challenges
- Continuous treatments are common in practice but poorly supported by existing tools
- Positivity violations occur frequently when human decision-making limits treatment exposure
- Limited toolkits provide comprehensive end-to-end solutions for real-world scenarios
Our paper specifically addresses these challenges in the context of financial debt collection, where the goal is to determine optimal write-down percentages to maximize recovery while minimizing loss.
The framework consists of six sequential, modular steps:
Challenge: High-dimensional observational data introduces computational complexity for causal discovery algorithms and iterative refinement with expert-knowledge.
Solution: Two-stage feature selection framework:
- Stage 1: Treatment-predictive feature selection using hybrid FCBF + Sequential Forward Selection
- Stage 2: Dual partial correlation analysis for confounder and outcome predictor identification
Output: Reduced adjustment set
Challenge: Algorithmic causal discovery alone is insufficient for reliable causal graph construction.
Solution: Hybrid approach combining:
- Algorithmic discovery: Ensemble of PC, FCI, and GES algorithms
- Domain expertise: Iterative refinement through expert validation
- Temporal constraints: Enforcement of known variable orderings
Output: Expert-validated causal graph and final adjustment set
Challenge: Systematic violations of positivity assumption in observational data.
Solution: Three-step model-agnostic procedure:
- Detection: Generalized Propensity Score (GPS) based violation quantification
- Quantification: Continuous severity measures across treatment space
- Remediation: Domain-informed data augmentation strategies
Output: Augmented dataset with improved treatment overlap
Challenge: Standard estimators designed for binary treatments poorly handle continuous interventions.
Solution: Benchmarking of three approaches:
- Linear regression with interactions: Interpretable baseline
- S-learner: Flexible single-model approach with regularization
- Modified AIPTW: Doubly-robust estimation adapted for continuous treatments
Output: Individual dose-response curves and treatment effect estimates
Challenge: Validating causal estimates without ground truth.
Solution: Comprehensive validation framework:
- Placebo tests: Treatment replacement to verify effect attribution
- Random common cause tests: Stability assessment via synthetic confounders
- E-value sensitivity analysis: Potential unmeasured confounding quantification for continuous treatments
- Qini curves: Uplift-oriented performance evaluation
Output: Validated estimates with robustness metrics and final estimate selection
Challenge: Translating causal estimates into actionable business decisions.
Solution: Counterfactual-driven optimization:
- Individual treatment recommendations: Personalized optimal write-down levels
- Expected value calculations: Cost-benefit analysis integration
- Policy simulation: Risk assessment under different intervention strategies
Output: Optimized treatment policies and decision support tools
# Clone the repository
git clone https://github.com/javiermoralh/causal-pipeline.git
cd causal-pipeline
# Create and activate virtual environment
python -m venv causal_env
source causal_env/bin/activate # On Windows: causal_env\Scripts\activate
# Install dependencies
pip install -r requirements.txtOur methodology demonstrates significant improvements over baseline approaches:
| Method | Mean Bias | 95% CI |
|---|---|---|
| Baseline (Full Features) | 0.387 | [0.375, 0.397] |
| Adjustment Set Only | 0.339 | [0.317, 0.359] |
| Proposed Pipeline | 0.231 | [0.219, 0.244] |
- 40.3% reduction in estimation bias compared to baseline
- 150x faster execution through efficient dimensionality reduction
- Improved precision with narrower confidence intervals
The main code to reproduce the paper results can be found in the numbered notebooks
causal-pipeline/
├── config/
├── data/
├── figs/
├── modules/
├── utils/
├── 01_data_generation.ipynb # Synthetic dataset creation
├── 02_dimensionality_reduction.ipynb
├── 03_causal_identification.ipynb
├── 04_positivity_handling.ipynb
├── 05_effect_estimation.ipynb
├── 06_evaluation_refutation.ipynb
└── 07_ablation_study_identification.ipynb
└── 08_ablation_study_estimates.ipynb
The specification of the method’s configuration, including correlation thresholds for dimensionality reduction, algorithmic choices for treatment-predictive feature derivation, and parameters for positivity violation detection, can be found in the notebooks.
# Run complete experimental results
python 01_data_generation.ipynb
python 02_dimensionality_reduction.ipynb
python 03_causal_identification.ipynb
python 04_positivity_handling.ipynb
python 05_effect_estimation.ipynb
python 06_evaluation_refutation.ipynb
python 07_ablation_study_identification.ipynb
python 08_ablation_study_estimates.ipynbThis project is licensed under the MIT License - see the LICENSE file for details.
If you use any of the contributions of this paper and this code in your research, please cite:
@inproceedings{causal-pipeline-2025,
title={An end-to-end pipeline for Causal ML with continuous treatments: An application to financial decision making},
author={Moral Hernández, Javier and Higuera-Cabañes, Clara and Ibraín, Álvaro},
booktitle={KDD2025},
series={KDD '25},
year={2025},
publisher={ACM},
address={Madrid, Spain},
url={https://github.com/javiermoralh/causal-pipeline}
}- Javier Moral Hernández - BBVA AI Factory - javier.moral.1996@gmail.com
- Clara Higuera-Cabañes - BBVA AI Factory - clara.higuera@bbva.com
- Álvaro Ibraín - BBVA AI Factory - alvaro.ibrain@bbva.com
For questions, issues, or collaboration opportunities, please open an issue or contact the authors directly.